Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Mahé

Showing results (111-120 of 143) with videos related to

Pageof 15
Sort By:
European Journal of Heart Failure|June 12, 2003
Aspirin alters arterial function in patients with chronic heart failure treated with ACE inhibitors: a dose-mediated deleterious effectChristophe Meune, Isabelle Mahé, Jean-Jacques Mourad, et al.
Thrombosis and Haemostasis|December 17, 2013
A model predicting fluindione dose requirement in elderly inpatients including genotypes, body weight, and amiodaroneCaroline Moreau, Eric Pautas, Charlotte Duverlie, et al.
Journal of Thrombosis and Haemostasis : JTH|September 17, 2021
The prognostic value of respiratory symptoms and performance status in ambulatory cancer patients and unsuspected pulmonary embolism; analysis of an international, prospective, observational cohort studyAnthony Maraveyas, Noémie Kraaijpoel, George Bozas, et al.
Thrombosis and Haemostasis|November 25, 2025
Tinzaparin Pharmacokinetics in Patients with Cancer: A Comparative Modeling StudyXavier Delavenne, Jean Escal, Dominique Helley, et al.
European Journal of Internal Medicine|May 25, 2026
Development and external validation of an international score to predict cancer 1 year after venous thromboembolismLuis Jara-Palomares, Behnood Bikdeli, David Jiménez, et al.
Cancers|September 9, 2022
Cancer Histology and Natural History of Patients with Lung Cancer and Venous ThromboembolismPedro Ruiz-Artacho, Ramón Lecumberri, Javier Trujillo-Santos, et al.
Research and Practice in Thrombosis and Haemostasis|April 22, 2026
Clinician perspectives on antithrombotic therapy management in advanced cancer: a multinational qualitative studyElin Baddeley, Carme Font, Isabelle Mahé, et al.
Thrombosis Research|July 12, 2025
"Who am I to say that I'm not going to take it": patient perspectives on decisions about antithrombotic therapy in the context of advanced cancerElin Baddeley, Carme Font, Isabelle Mahé, et al.
Haematologica|May 28, 2017
Comparison of risk prediction scores for venous thromboembolism in cancer patients: a prospective cohort studyNick van Es, Marcello Di Nisio, Gabriela Cesarman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 23, 2019
Treatment and Long-Term Clinical Outcomes of Incidental Pulmonary Embolism in Patients With Cancer: An International Prospective Cohort StudyNoémie Kraaijpoel, Suzanne M Bleker, Guy Meyer, et al.
Pageof 15

Showing results (111-120 of 143) with videos related to

Sort By:
Pageof 15
European Journal of Heart Failure|June 12, 2003
Aspirin alters arterial function in patients with chronic heart failure treated with ACE inhibitors: a dose-mediated deleterious effectChristophe Meune, Isabelle Mahé, Jean-Jacques Mourad, et al.
Thrombosis and Haemostasis|December 17, 2013
A model predicting fluindione dose requirement in elderly inpatients including genotypes, body weight, and amiodaroneCaroline Moreau, Eric Pautas, Charlotte Duverlie, et al.
Journal of Thrombosis and Haemostasis : JTH|September 17, 2021
The prognostic value of respiratory symptoms and performance status in ambulatory cancer patients and unsuspected pulmonary embolism; analysis of an international, prospective, observational cohort studyAnthony Maraveyas, Noémie Kraaijpoel, George Bozas, et al.
Thrombosis and Haemostasis|November 25, 2025
Tinzaparin Pharmacokinetics in Patients with Cancer: A Comparative Modeling StudyXavier Delavenne, Jean Escal, Dominique Helley, et al.
European Journal of Internal Medicine|May 25, 2026
Development and external validation of an international score to predict cancer 1 year after venous thromboembolismLuis Jara-Palomares, Behnood Bikdeli, David Jiménez, et al.
Cancers|September 9, 2022
Cancer Histology and Natural History of Patients with Lung Cancer and Venous ThromboembolismPedro Ruiz-Artacho, Ramón Lecumberri, Javier Trujillo-Santos, et al.
Research and Practice in Thrombosis and Haemostasis|April 22, 2026
Clinician perspectives on antithrombotic therapy management in advanced cancer: a multinational qualitative studyElin Baddeley, Carme Font, Isabelle Mahé, et al.
Thrombosis Research|July 12, 2025
"Who am I to say that I'm not going to take it": patient perspectives on decisions about antithrombotic therapy in the context of advanced cancerElin Baddeley, Carme Font, Isabelle Mahé, et al.
Haematologica|May 28, 2017
Comparison of risk prediction scores for venous thromboembolism in cancer patients: a prospective cohort studyNick van Es, Marcello Di Nisio, Gabriela Cesarman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 23, 2019
Treatment and Long-Term Clinical Outcomes of Incidental Pulmonary Embolism in Patients With Cancer: An International Prospective Cohort StudyNoémie Kraaijpoel, Suzanne M Bleker, Guy Meyer, et al.
Pageof 15